Adam Gridley, President and CEO at HISTOGENICS CORP (HSGX), bought 2,000 shares at $2.15 ($4K) on 2018-05-16, disclosed to the SEC on 2018-05-18.
Open-market purchase of $4k HSGX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |